From: Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome
Disease types
CR (cases)
PR (cases)
NR (cases)
Total
Effective rate (%)
MN
9
17
10
36
72.2
MsPGN
6
4
1
11
90.9
MCN
15
93.3
FSGS
0
5
SLE
16
26
80.7
HSPN
2
7
100
35
43
22
78% (78/100)